From alchemy to IPO: the business of biotechnology
It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written b...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
Perseus Publ.
2000
|
| Ausgabe: | 1. print. |
| Schlagworte: | |
| Zusammenfassung: | It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the ʼ70s to todayʼs heyday of new solutions and breakthrough treatments. |
| Beschreibung: | XV, 253 S. |
| ISBN: | 0738202533 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV013372580 | ||
| 003 | DE-604 | ||
| 005 | 20010730 | ||
| 007 | t | ||
| 008 | 001002s2000 |||| 00||| eng d | ||
| 020 | |a 0738202533 |9 0-7382-0253-3 | ||
| 035 | |a (OCoLC)46846836 | ||
| 035 | |a (DE-599)BVBBV013372580 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-473 | ||
| 050 | 0 | |a HD9999.B44 | |
| 050 | 0 | |a TP248.2 | |
| 082 | 0 | |a 660.6 |2 21 | |
| 082 | 0 | |a 338.476606 |2 21 | |
| 084 | |a QR 529 |0 (DE-625)142048: |2 rvk | ||
| 100 | 1 | |a Robbins-Roth, Cynthia |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a From alchemy to IPO |b the business of biotechnology |c Cynthia Robbins-Roth |
| 250 | |a 1. print. | ||
| 264 | 1 | |a Cambridge, Mass. |b Perseus Publ. |c 2000 | |
| 300 | |a XV, 253 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 520 | 3 | |a It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the ʼ70s to todayʼs heyday of new solutions and breakthrough treatments. | |
| 650 | 7 | |a Biotechnologie |2 gtt | |
| 650 | 4 | |a Biomedical Technology | |
| 650 | 4 | |a Biotechnology | |
| 650 | 4 | |a Industry | |
| 650 | 0 | 7 | |a Biotechnologie |0 (DE-588)4069491-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Biotechnologische Industrie |0 (DE-588)4208106-3 |2 gnd |9 rswk-swf |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Biotechnologische Industrie |0 (DE-588)4208106-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 1 | 1 | |a Biotechnologie |0 (DE-588)4069491-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009120070 | ||
Datensatz im Suchindex
| _version_ | 1804128149403860992 |
|---|---|
| any_adam_object | |
| author | Robbins-Roth, Cynthia |
| author_facet | Robbins-Roth, Cynthia |
| author_role | aut |
| author_sort | Robbins-Roth, Cynthia |
| author_variant | c r r crr |
| building | Verbundindex |
| bvnumber | BV013372580 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9999 |
| callnumber-raw | HD9999.B44 TP248.2 |
| callnumber-search | HD9999.B44 TP248.2 |
| callnumber-sort | HD 49999 B44 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| classification_rvk | QR 529 |
| ctrlnum | (OCoLC)46846836 (DE-599)BVBBV013372580 |
| dewey-full | 660.6 338.476606 |
| dewey-hundreds | 600 - Technology (Applied sciences) 300 - Social sciences |
| dewey-ones | 660 - Chemical engineering 338 - Production |
| dewey-raw | 660.6 338.476606 |
| dewey-search | 660.6 338.476606 |
| dewey-sort | 3660.6 |
| dewey-tens | 660 - Chemical engineering 330 - Economics |
| discipline | Chemie / Pharmazie Wirtschaftswissenschaften |
| edition | 1. print. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02043nam a2200493 c 4500</leader><controlfield tag="001">BV013372580</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20010730 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">001002s2000 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0738202533</subfield><subfield code="9">0-7382-0253-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)46846836</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013372580</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-473</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9999.B44</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TP248.2</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">660.6</subfield><subfield code="2">21</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.476606</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 529</subfield><subfield code="0">(DE-625)142048:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Robbins-Roth, Cynthia</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">From alchemy to IPO</subfield><subfield code="b">the business of biotechnology</subfield><subfield code="c">Cynthia Robbins-Roth</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. print.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">Perseus Publ.</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XV, 253 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the ʼ70s to todayʼs heyday of new solutions and breakthrough treatments.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biotechnologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedical Technology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industry</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologische Industrie</subfield><subfield code="0">(DE-588)4208106-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Biotechnologische Industrie</subfield><subfield code="0">(DE-588)4208106-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009120070</subfield></datafield></record></collection> |
| geographic | USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV013372580 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:44:39Z |
| institution | BVB |
| isbn | 0738202533 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009120070 |
| oclc_num | 46846836 |
| open_access_boolean | |
| owner | DE-473 DE-BY-UBG |
| owner_facet | DE-473 DE-BY-UBG |
| physical | XV, 253 S. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Perseus Publ. |
| record_format | marc |
| spelling | Robbins-Roth, Cynthia Verfasser aut From alchemy to IPO the business of biotechnology Cynthia Robbins-Roth 1. print. Cambridge, Mass. Perseus Publ. 2000 XV, 253 S. txt rdacontent n rdamedia nc rdacarrier It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the ʼ70s to todayʼs heyday of new solutions and breakthrough treatments. Biotechnologie gtt Biomedical Technology Biotechnology Industry Biotechnologie (DE-588)4069491-4 gnd rswk-swf Biotechnologische Industrie (DE-588)4208106-3 gnd rswk-swf USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Biotechnologische Industrie (DE-588)4208106-3 s DE-604 Biotechnologie (DE-588)4069491-4 s |
| spellingShingle | Robbins-Roth, Cynthia From alchemy to IPO the business of biotechnology Biotechnologie gtt Biomedical Technology Biotechnology Industry Biotechnologie (DE-588)4069491-4 gnd Biotechnologische Industrie (DE-588)4208106-3 gnd |
| subject_GND | (DE-588)4069491-4 (DE-588)4208106-3 (DE-588)4078704-7 |
| title | From alchemy to IPO the business of biotechnology |
| title_auth | From alchemy to IPO the business of biotechnology |
| title_exact_search | From alchemy to IPO the business of biotechnology |
| title_full | From alchemy to IPO the business of biotechnology Cynthia Robbins-Roth |
| title_fullStr | From alchemy to IPO the business of biotechnology Cynthia Robbins-Roth |
| title_full_unstemmed | From alchemy to IPO the business of biotechnology Cynthia Robbins-Roth |
| title_short | From alchemy to IPO |
| title_sort | from alchemy to ipo the business of biotechnology |
| title_sub | the business of biotechnology |
| topic | Biotechnologie gtt Biomedical Technology Biotechnology Industry Biotechnologie (DE-588)4069491-4 gnd Biotechnologische Industrie (DE-588)4208106-3 gnd |
| topic_facet | Biotechnologie Biomedical Technology Biotechnology Industry Biotechnologische Industrie USA |
| work_keys_str_mv | AT robbinsrothcynthia fromalchemytoipothebusinessofbiotechnology |